Tag

Gilead Sciences

1 article

Gilead Q2 Loss $6.75, Revenue +10%

Gilead posted Q2 adjusted loss of $6.75 per share, beating consensus of $7.31, while revenue rose 10% to $7.8 billion. The loss was driven by $9.08 per share in‑process R&D expenses and taxes from rec